ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues
(ERIS)
XNSE:ERIS, XBOM:ERIS
ERIS Lifesciences Ltd Q4FY24; 31% rise in Profits
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues
ERIS Lifesciences Ltd Q3FY24; 1% rise in Profits
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues
ERIS Lifesciences Ltd Q2FY24; 3% rise in Profits
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues
ERIS Lifesciences Ltd Q1FY24; 1% rise in Profits
ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues
Eris Lifesciences Ltd (ERIS) Q2 FY23 Earnings Concall Transcript
Eris Lifesciences Ltd (NSE:ERIS) Q2 FY23 Earnings Concall dated Oct. 20, 2022 Corporate Participants: Krishnakumar Vaidyanathan -- Executive Director and Chief Operating